Advertisement
Advertisement
U.S. markets open in 9 hours 14 minutes
Advertisement
Advertisement
Advertisement
Advertisement

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.8400+0.0300 (+1.66%)
At close: 04:00PM EDT
1.8900 +0.05 (+2.72%)
After hours: 05:04PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • R
    Ron
    Prior to the trial delay Dmac was trading at about 2.30.
  • R
    Ron
    Aug 11 I expect news on FDA study.
  • R
    Rocket man
    Strong possibility of success of novel stroke treatment and prevention medication with 10 billion dollar market too good to pass on. Buying more.

    Think about it. In 12-18 months interim data with treatment and prevention numbers.

    Even with buy out or partnership…their share of profits HUGE on per share basis.

    >100 fold increase in SP certainly not out of the question. ….as I said. Too good to pass up on.
    Bullish
  • A
    Anonymous
    What do they say about hindsight ,,,,,,,,,,well
    It is already working itself out , don’t you see, everything is just the way it supposed to be , savor it, lol, this is the opportunity that you wished for and It has already been a Success, reason why I’m here,in the 1st place 🌟 DMAC is one of a kind and a WINNER without a doubt💥
  • R
    Ron
    As far as bad events go a small drop in blood pressure is pretty mild. At least no one suffered as a result. They seem to be on top of the cause. This may be a huge buying opportunity!
    Bullish
  • M
    MIke
    The person dumping shares on June 24 down to $1.62 must have a crystal ball :)
  • D
    David
    PATIENTS BLOOD PRESSURE DROP WHEN THEY SEE ROUND PLASTIC BAGS INSTEAD OF SQUARE..
    KEEP EM GOING RICK PAULS! LOL!!!! .50 CENTS SHORTLY
    Bearish
  • J
    JustAskin
    It might be worth knowing who was selling all those shares back on June 27?
  • x
    x
    This is a blessing in disguise, just imagine what would have happened if this occurred after they launched the product.
    Bullish
  • D
    Darwin
    Wonder what’s the timeline for the company to resume the trial?
  • x
    x
    My mother had a stroke, it was so disheartening with out any treatments except physical therapy.
  • J
    John
    Just awful. Going down big time. Another failure.
    Bearish
  • R
    Ron
    As an investor in DMAC, I’d like a timeline of their action plan to restart their trial, with regular updates on their progress.
  • C
    Constantine
    What happed it dropped 40 cents right at the close? I see no news.
  • c
    chevies
    Ouch!
  • J
    JC
    Wonder when the results from the chronic kidney disease study will be released?
  • R
    Ron
    Fed increase was .75%. Borrowing Prime at 2.25%. No impact on this company until 2024, but for those who are worried, all we need now is the green light for testing again for another big bump.
  • R
    Ron
    On sale. Remember cash runway until 2024. Interest rates will not impact this company for a while.
  • D
    David
    LOL...ITS TIME TO SHUT THE DOORS...
    Bearish
Advertisement
Advertisement